Skip to main content
Article thumbnail
Location of Repository

Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy

By F. Leyva, P. W. Foley, B. Stegemann, J. A. Ward, L. L. Ng, M. P. Frenneaux, F. Regoli, R. E. Smith and A. Auricchio


Objective: To develop and validate a prognostic risk index of cardiovascular mortality after cardiac resynchronisation therapy (CRT).\ud \ud Design: Prospective cohort study.\ud \ud Setting: District general hospital.\ud \ud Patients: 148 patients with heart failure (mean age 66.7 (SD 10.4) years), New York Heart Association class III or IV, LVEF <35%) who underwent CRT.\ud \ud Interventions: CRT device implantation.\ud \ud Main outcome measures: Value of a composite index in predicting cardiovascular mortality, validated internally by bootstrapping. The predictive value of the index was compared to factors that are known to predict mortality in patients with heart failure.\ud \ud Results: All patients underwent assessment of 16 prognostic risk factors, including cardiovascular magnetic resonance (CMR) measures of myocardial scarring (gadolinium-hyperenhancement) and dyssynchrony, before implantation. Clinical events were assessed after a median follow-up of 913 (interquartile range 967) days. At follow-up, 37/148 (25%) of patients died from cardiovascular causes. In Cox proportional hazards analyses, (DSC) Dyssynchrony, posterolateral Scar location (both p<0.0001) and Creatinine (p = 0.0046) emerged as independent predictors of cardiovascular mortality. The DSC index, derived from these variables combined, emerged as a powerful predictor of cardiovascular mortality. Compared to patients with a DSC <3, cardiovascular mortality in patients in the intermediate DSC index (3–5; HR: 11.1 (95% confidence interval (CI) 3.00 to 41.1), p = 0.0003) and high DSC index (⩾5; HR: 30.5 (95% CI 9.15 to 101.8), p<0.0001) were higher. Bootstrap validation confirmed excellent calibration and internal validity of the prediction model.\ud \ud Conclusion: The DSC index, derived from a standard CMR scan and plasma creatinine before implantation, is a powerful predictor of cardiovascular mortality after CRT

Publisher: BMJ Publishing Group
Year: 2009
DOI identifier: 10.1136/hrt.2009.173880
OAI identifier:

Suggested articles


  1. Assessment of cardiac asynchrony by radionuclide phase analysis: correlation with ventricular function in patients with narrow or prolonged QRS interval. doi
  2. (2006). Assessment of left ventricular dyssynchrony in patients with conduction delay and idiopathic dilated cardiomyopathy. doi
  3. Assessment of longitudinal and radial ventricular dyssynchrony in ischemic and nonischemic chronic systolic heart failure: a two-dimensional echocardiographic speckle-tracking strain study. doi
  4. (1979). Bootstrap method: another look at the jacknife. Ann Stat doi
  5. (1997). Cardiac arrest and sudden cardiac death. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. doi
  6. (2005). Cardiac dyssynchrony analysis using circumferential versus longitudinal strain: Implications for assessing cardiac resynchronization. Circulation doi
  7. (2007). Cardiac resynchronisation therapy for the treatment of heart failure: NICE technology appraisal guidance. Heart doi
  8. Cardiac resynchronization therapy: Part 1— Issues before device implantation.
  9. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. doi
  10. Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. doi
  11. (1999). Determination of the optimal atrioventricular delay in DDD pacing: comparison between echo and peak endocardial acceleration measurements. doi
  12. (1997). Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation doi
  13. (2003). Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation doi
  14. Echocardiographic parameters of mechanical synchrony in healthy individuals. doi
  15. Echocardiographic quantification of left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy. doi
  16. (2007). Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy. Pacing Clin Elctrophysiol doi
  17. (2006). Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation doi
  18. Feasibility of adjusting paced left ventricular activation by manipulating stimulus strength. doi
  19. for the Cardiac Resynchronization-Heart Failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. doi
  20. for the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced heart failure. doi
  21. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. doi
  22. Interventricular and intraventricular dyssynchrony in idiopathic dilated cardiomyopathy. A prognostic study with Fourier phase analysis of radionuclide angioscintigraphy. doi
  23. Intra-left ventricular electromechanical asynchrony: a new predictor of severe cardiac events in heart failure patients. doi
  24. Intraventricular dyssynchrony predicts mortality and morbidity following cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging. doi
  25. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. doi
  26. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. doi
  27. Magnetic resonance imaging assessment of ventricular dyssynchrony: current and emerging concepts. doi
  28. (1999). Mapping propagation of mechanical activation in the paced heart with MRI tagging.
  29. (1996). Multivariate prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med doi
  30. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. doi
  31. (1988). Nonlinear regression analysis and its applications. doi
  32. Partial residuals for the proportional hazards regression model. doi
  33. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. doi
  34. (1984). Regression modelling strategies for improved prognostic prediction. Stat Med doi
  35. (2000). Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation doi
  36. (2008). Results of the predictors of response to CRT (PROSPECT) Trial. Circulation doi
  37. (2002). Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council of the American Heart Association. Circulation doi
  38. (2007). The Design Package.
  39. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. doi
  40. The Seattle Heart Failure Model: prediction of survival in heart failure. doi
  41. (2003). Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.